Public Health Agency of Canada
Symbol of the Government of Canada

ARCHIVED - 2009 - Preliminary Results

Warning This page has been archived.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of CanadaExternal link, you can request alternate formats on the "Contact Us" page.

Table 17. Number of antimicrobial classes in resistance patterns of Salmonella isolates from pigs, by serovar; Surveillance of Animal Clinical Isolates, 2009

Serovar Number (%) of isolates Number of isolates by number of antimicrobial classes in the resistance pattern Number of isolates resistant by antimicrobial class and antimicrobial
Aminoglycosides β-lactams Folate pathways inhibitors Phenicols Quinolones Tetracyclines
  1 2–3 4–5 6 AMK GEN KAN STR AMP AMC CRO FOX TIO SSS SXT CHL CIP NAL TET
Typhimurium 48 (24.6) 4   8 36     2 20 38 39 2 2 2 2 42 13 30     44
Derby 27 (13.8) 4 2 20 1         21           21   1     23
Typhimurium var. 5- 21 (10.8) 1 1 2 17     1 14 17 18         19 2 12     19
Infantis 12 (6.2) 11 1                                   1
Brandenburg 8 (4.1) 4 2 1 1     1 1 2 1   1   1 1 1 1     4
Schwarzengrund 8 (4.1) 3   4 1       1 5 1         5         5
Mbandaka 7 (3.6) 3   3 1     1 1 3 1         3 1       4
I 4,[5],12:i:- 6 (3.1) 1     5       3 5 5         5 2 4     5
Worthington 6 (3.1) 3   3           3           3         3
Bovismorbificans 5 (2.6)   1   4       2 4 5 2 2 2 2 4   2     4
I 4,[5],12:-:- 4 (2.1)   1 2 1         3 1         3   1     4
Less common serovars 43 (22.1) 17 4 12 10     2 8 16 10 3 3 3 3 19 5 8     25
Total 195 (100) 51 12 55 77     7 50 117 81 7 8 7 8 125 24 59     141

Serovars represented by less than 2% of isolates were classified as “Less common serovars”.
Serovar identity was not available for 3 isolates.

Return to Table 17